Evidence map›Paper›PMID 25104021›Full record

ArticleNucleic acids research2014

HIV-1 Nef and KSHV oncogene K1 synergistically promote angiogenesis by inducing cellular miR-718 to regulate the PTEN/AKT/mTOR signaling pathway.

Min Xue, Shuihong Yao, Minmin Hu, Wan Li, Tingting Hao, Feng Zhou, Xiaofei Zhu, Hongmei Lu, Di Qin, Qin Yan and 3 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 67 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 1 synthesis or guideline pooled it, 93 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Trained Immunity and HIV Infection.Frontiers in immunology · 2022
    Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Min XueState Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, P.R. China Key Laboratory of Pathogen Biology of Jiangsu Province, Nanjing Medical University, Nanjing, P.R. China Department of Microbiology, Nanjing Medical University, Nanjing 210029, P.R. China Department of Physiology, Xuzhou Medical College, Xuzhou, Jiangsu 221004, P.R. China.
Shuihong YaoMedical School, Quzhou College of Technology, Quzhou 324000, P.R. China.
Minmin HuDepartment of Microbiology, Nanjing Medical University, Nanjing 210029, P.R. China.
Wan LiDepartment of Microbiology, Nanjing Medical University, Nanjing 210029, P.R. China.
Tingting HaoDepartment of Microbiology, Nanjing Medical University, Nanjing 210029, P.R. China.
Feng ZhouDepartment of Microbiology, Nanjing Medical University, Nanjing 210029, P.R. China.
Xiaofei ZhuDepartment of Microbiology, Nanjing Medical University, Nanjing 210029, P.R. China.
Hongmei LuDepartment of Obstetrics, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, P.R. China.
Di QinDepartment of Microbiology, Nanjing Medical University, Nanjing 210029, P.R. China.
Qin YanDepartment of Microbiology, Nanjing Medical University, Nanjing 210029, P.R. China clu@njmu.edu.cn.
Jianzhong ZhuCancer Virology Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15232, USA.
Shou-Jiang GaoDepartment of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
Chun LuState Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, P.R. China Key Laboratory of Pathogen Biology of Jiangsu Province, Nanjing Medical University, Nanjing, P.R. China Department of Microbiology, Nanjing Medical University, Nanjing 210029, P.R. China clu@njmu.edu.cn.
Nanjing Medical University · CNQuzhou College of Technology · CNUniversity of Southern California · USUPMC Hillman Cancer Center · USXuzhou Medical College · CN

Funding

Roles of the K3 and K5 in KSHV Persistence and PathogenesisP01CA180779 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JUNG, JAE U · 2013 to 2017
$7.3M
Regulation of KSHV replication by N6-methyladenosine (m6A) - Diversity SupplementR01CA124332 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI GAO, SHOU-JIANG · 2007 to 2025
$5.0M
KSHV microRNAs in cellular transformation and tumorigenesisR01CA177377 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI GAO, SHOU-JIANG · 2013 to 2015
$596k
NCI NIH HHS P01 CA180779NCI NIH HHS R01 CA124332NCI NIH HHS R01 CA177377
6 · The paper itself

Abstract

Kaposi's sarcoma (KS) is an AIDS-defining cancer with aberrant neovascularization caused by KS-associated herpesvirus (KSHV). Although the interaction between HIV-1 and KSHV plays a pivotal role in promoting the aggressive manifestations of KS, the pathogenesis underlying AIDS-KS remains largely unknown. Here we examined HIV-1 Nef protein promotion of KSHV oncoprotein K1-induced angiogenesis. We showed that both internalized and ectopic expression of Nef in endothelial cells synergized with K1 to facilitate vascular tube formation and cell proliferation, and enhance angiogenesis in a chicken CAM model. In vivo experiments further indicated that Nef accelerated K1-induced angiogenesis and tumorigenesis in athymic nu/nu mice. Mechanistic studies revealed that Nef and K1 synergistically activated PI3K/AKT/mTOR signaling by downregulating PTEN. Furthermore, Nef and K1 induced cellular miR-718, which inhibited PTEN expression by directly targeting a seed sequence in the 3' UTR of its mRNA. Inhibition of miR-718 expression increased PTEN synthesis and suppressed the synergistic effect of Nef- and K1-induced angiogenesis and tumorigenesis. These results indicate that, by targeting PTEN, miR-718 mediates Nef- and K1-induced angiogenesis via activation of AKT/mTOR signaling. Our results demonstrate an essential role of miR-718/AKT/mTOR axis in AIDS-KS and thus may represent an attractive therapeutic target.

Indexed as

Neovascularization, PhysiologicSignal TransductionAnimalsCarcinogenesisCell LineCell ProliferationChick EmbryoEndothelial CellsHumansMaleMiceMice, Inbred BALB CMice, NudeMicroRNAsnef Gene Products, Human Immunodeficiency VirusProto-Oncogene Proteins c-aktK1 protein, Human herpesvirus 8MicroRNAsMIRN718 microRNA, humannef Gene Products, Human Immunodeficiency Virusnef protein, Human immunodeficiency virus 1Proto-Oncogene Proteins c-aktPTEN PhosphohydrolaseTOR Serine-Threonine KinasesViral Proteins

Identifiers

PMID25104021
PMCPMC4150761
OpenAlexW2171069693

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.